 |
 |

A Novel Type of Hereditary Motor and Sensory Neuropathy Characterized by a Mild Phenotype
Peter De Jonghe, MD, PhD;
Vincent Timmerman, PhD;
Eva Nelis, PhD;
Els De Vriendt;
Ann Löfgren, MSc;
Chantal Ceuterick, PhD;
Jean-Jacques Martin, MD, PhD;
Christine Van Broeckhoven, PhD, DrSc
Arch Neurol. 1999;56:1283-1288.
Background Three loci for autosomal dominant hereditary motor and sensory neuropathy type I (HMSN I) or Charcot-Marie-Tooth disease type 1 (CMT1) have been identified on chromosomes 17p11.2 (CMT1A), 1q21-q23 (CMT1B), and 10q21.1-q22.1 (designated here as CMT1D). The genes involved are peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ), and the early growth response element 2 (EGR2), respectively. Probably a fourth locus (CMT1C) exists since some autosomal dominant HMSN I families have been excluded for linkage with the CMT1A and CMT1B loci. Four loci for autosomal dominant hereditary motor and sensory neuropathy type II (HMSN II) or Charcot-Marie-Tooth disease type 2 (CMT2) have been localized on chromosomes 1p35-p36 (CMT2A), 3q13-q22 (CMT2B), 7p14 (CMT2D), and 3p (HMSN-P).
Objective To describe the clinical, electrophysiologic, and neuropathological features of a novel type of Charcot-Marie-Tooth disease.
Patients and Methods We performed linkage studies with anonymous DNA markers flanking the known CMT1 and CMT2 loci. Patients and their relatives underwent clinical neurologic examination and electrophysiologic testing. In the proband, a sural nerve biopsy specimen was examined.
Results Linkage studies excluded all known CMT1 and CMT2 loci. The clinical phenotype is mild and almost all affected individuals remain asymptomatic. Electrophysiologic and histopathological studies showed signs of a demyelinating neuropathy, but the phenotype is unusual for either autosomal dominant HMSN I or HMSN II.
Conclusion Our findings indicate that the HMSN in this family represents a novel clinical and genetic entity.
From the Laboratory of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), Born-Bunge Foundation (BBS), University of Antwerp (UIA), Department of Biochemistry (Drs De Jonghe, Timmerman, Nelis, and Van Broeckhoven and Mss De Vriendt and Löfgren), the Department of Neurology, University Hospital Antwerp (UZA) (Drs De Jonghe and Martin), and Laboratory of Neuropathology, Born-Bunge Foundation (BBS) (Drs Ceuterick and Martin), Antwerpen, Belgium.
RELATED ARTICLES
Hereditary Motor and Sensory Neuropathy: The Plot Thickens
David Pleasure
Arch Neurol. 1999;56(10):1195.
EXTRACT
| FULL TEXT
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(10):1302-1303.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hereditary Motor and Sensory Neuropathy: The Plot Thickens
Pleasure
Arch Neurol 1999;56:1195-1195.
FULL TEXT
|